CELL DEATH DISCOV 润色咨询

Cell Death Discovery

出版年份：暂无数据 年文章数：928 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1224377, encodeId=35f812243e740, content=偏重的研究方向：机制<br>经验分享：一审返修第二天就decision made，现在又过了三天了还没有发邮件，不清楚咋回事，好焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220120/e28ed7e5bf2d4eeb9c348df0072a7d10/99f48f1006314a1d9056038733877ef3.jpg, createdBy=a1235642632, createdName=打工小熊🐻, createdTime=Sat Jun 04 11:34:41 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184254, encodeId=7c4e1184254d3, content=请问大家缴费以后收到invoice了吗，怎么找杂志要invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ec24671199, createdName=303367978, createdTime=Fri Jan 14 16:06:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198273, encodeId=5e5d11982e3b7, content=偏重的研究方向：机制<br>经验分享：Cell death disease建议转投到cell death discovery，manuscripts under consideration后一个月再次manuscripts under consideration这种是什么情况？文件里见有外审文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220120/e28ed7e5bf2d4eeb9c348df0072a7d10/99f48f1006314a1d9056038733877ef3.jpg, createdBy=a1235642632, createdName=打工小熊🐻, createdTime=Tue Mar 01 09:28:13 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198524, encodeId=9062119852484, content=偏重的研究方向：机制;肿瘤<br>经验分享：最近审稿怎么这么慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd595570164, createdName=ms031, createdTime=Tue Mar 01 23:22:15 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003085, encodeId=01d31003085b3, content=各位大佬，你们支付过版面费后，会收到invoice嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Tue Jul 27 19:06:00 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104205, encodeId=b58e2104205a7, content=偏重的研究方向：肿瘤<br>经验分享：已经35天，还在Manuscript Under Consideration，写催稿信说已经送外审，还没有意见回来。。。。好煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea4735673, createdName=ms052lr, createdTime=Sun Dec 04 08:58:36 CST 2022, time=2022-12-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2152246, encodeId=eb00215224682, content=请问大佬们，7月18号发邮件送审了，状态显示为under consideration. 8月10号又出现了一个新的under consideration，也没发邮件，这是什么情况呢？是换审稿人了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc998444126, createdName=ms9000001100504946, createdTime=Fri Aug 11 12:15:43 CST 2023, time=2023-08-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2115901, encodeId=724a2115901ae, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：机制;肿瘤;非编码RNA<br>经验分享：折腾了4个月，总算原则性接收，也和大家分享一下过程： 第一轮 221029 Manuscript Received/Editor Assigned 221031 Manuscript UnderConsideration 221207 Manuscript Under Consideration 221218 Decision Made 221219 Decision Sent to Author/Waiting for Revision 第二轮 他修回是稿号后+R，不分大小都是Revise要重新提交 230113 Manuscript Received/Editor Assigned 230116 Manuscript UnderConsideration 230215 Manuscript Under Consideration 230218 Decision Made 230221 原则性接收 等上传再校稿，邮件写的是正式接收后缴费 二修基本1个月的时候非常焦虑，总的来说速度还算快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea4735673, createdName=ms052lr, createdTime=Wed Feb 22 11:36:34 CST 2023, time=2023-02-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0<br>经验分享：under consideration80天了，谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208246, encodeId=22051208246f3, content=这个杂志是什么时候要求交版面费啊？我proof都已经确认提交了，还没收到缴费的邮件。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/08/9c7077d12f45357f09cc4b2d21c25010.jpg, createdBy=f21b1476331, createdName=silencelang, createdTime=Sat Apr 02 22:06:41 CST 2022, time=2022-04-02, status=1, ipAttribution=)]
    2022-06-04 打工小熊🐻

    偏重的研究方向：机制
    经验分享：一审返修第二天就decision made，现在又过了三天了还没有发邮件，不清楚咋回事，好焦虑

    20

    展开20条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1224377, encodeId=35f812243e740, content=偏重的研究方向：机制<br>经验分享：一审返修第二天就decision made，现在又过了三天了还没有发邮件，不清楚咋回事，好焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220120/e28ed7e5bf2d4eeb9c348df0072a7d10/99f48f1006314a1d9056038733877ef3.jpg, createdBy=a1235642632, createdName=打工小熊🐻, createdTime=Sat Jun 04 11:34:41 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184254, encodeId=7c4e1184254d3, content=请问大家缴费以后收到invoice了吗，怎么找杂志要invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ec24671199, createdName=303367978, createdTime=Fri Jan 14 16:06:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198273, encodeId=5e5d11982e3b7, content=偏重的研究方向：机制<br>经验分享：Cell death disease建议转投到cell death discovery，manuscripts under consideration后一个月再次manuscripts under consideration这种是什么情况？文件里见有外审文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220120/e28ed7e5bf2d4eeb9c348df0072a7d10/99f48f1006314a1d9056038733877ef3.jpg, createdBy=a1235642632, createdName=打工小熊🐻, createdTime=Tue Mar 01 09:28:13 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198524, encodeId=9062119852484, content=偏重的研究方向：机制;肿瘤<br>经验分享：最近审稿怎么这么慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd595570164, createdName=ms031, createdTime=Tue Mar 01 23:22:15 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003085, encodeId=01d31003085b3, content=各位大佬，你们支付过版面费后，会收到invoice嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Tue Jul 27 19:06:00 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104205, encodeId=b58e2104205a7, content=偏重的研究方向：肿瘤<br>经验分享：已经35天，还在Manuscript Under Consideration，写催稿信说已经送外审，还没有意见回来。。。。好煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea4735673, createdName=ms052lr, createdTime=Sun Dec 04 08:58:36 CST 2022, time=2022-12-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2152246, encodeId=eb00215224682, content=请问大佬们，7月18号发邮件送审了，状态显示为under consideration. 8月10号又出现了一个新的under consideration，也没发邮件，这是什么情况呢？是换审稿人了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc998444126, createdName=ms9000001100504946, createdTime=Fri Aug 11 12:15:43 CST 2023, time=2023-08-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2115901, encodeId=724a2115901ae, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：机制;肿瘤;非编码RNA<br>经验分享：折腾了4个月，总算原则性接收，也和大家分享一下过程： 第一轮 221029 Manuscript Received/Editor Assigned 221031 Manuscript UnderConsideration 221207 Manuscript Under Consideration 221218 Decision Made 221219 Decision Sent to Author/Waiting for Revision 第二轮 他修回是稿号后+R，不分大小都是Revise要重新提交 230113 Manuscript Received/Editor Assigned 230116 Manuscript UnderConsideration 230215 Manuscript Under Consideration 230218 Decision Made 230221 原则性接收 等上传再校稿，邮件写的是正式接收后缴费 二修基本1个月的时候非常焦虑，总的来说速度还算快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea4735673, createdName=ms052lr, createdTime=Wed Feb 22 11:36:34 CST 2023, time=2023-02-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0<br>经验分享：under consideration80天了，谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208246, encodeId=22051208246f3, content=这个杂志是什么时候要求交版面费啊？我proof都已经确认提交了，还没收到缴费的邮件。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/08/9c7077d12f45357f09cc4b2d21c25010.jpg, createdBy=f21b1476331, createdName=silencelang, createdTime=Sat Apr 02 22:06:41 CST 2022, time=2022-04-02, status=1, ipAttribution=)]
    2022-01-14 303367978

    请问大家缴费以后收到invoice了吗，怎么找杂志要invoice

    18

    展开18条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1224377, encodeId=35f812243e740, content=偏重的研究方向：机制<br>经验分享：一审返修第二天就decision made，现在又过了三天了还没有发邮件，不清楚咋回事，好焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220120/e28ed7e5bf2d4eeb9c348df0072a7d10/99f48f1006314a1d9056038733877ef3.jpg, createdBy=a1235642632, createdName=打工小熊🐻, createdTime=Sat Jun 04 11:34:41 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184254, encodeId=7c4e1184254d3, content=请问大家缴费以后收到invoice了吗，怎么找杂志要invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ec24671199, createdName=303367978, createdTime=Fri Jan 14 16:06:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198273, encodeId=5e5d11982e3b7, content=偏重的研究方向：机制<br>经验分享：Cell death disease建议转投到cell death discovery，manuscripts under consideration后一个月再次manuscripts under consideration这种是什么情况？文件里见有外审文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220120/e28ed7e5bf2d4eeb9c348df0072a7d10/99f48f1006314a1d9056038733877ef3.jpg, createdBy=a1235642632, createdName=打工小熊🐻, createdTime=Tue Mar 01 09:28:13 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198524, encodeId=9062119852484, content=偏重的研究方向：机制;肿瘤<br>经验分享：最近审稿怎么这么慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd595570164, createdName=ms031, createdTime=Tue Mar 01 23:22:15 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003085, encodeId=01d31003085b3, content=各位大佬，你们支付过版面费后，会收到invoice嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Tue Jul 27 19:06:00 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104205, encodeId=b58e2104205a7, content=偏重的研究方向：肿瘤<br>经验分享：已经35天，还在Manuscript Under Consideration，写催稿信说已经送外审，还没有意见回来。。。。好煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea4735673, createdName=ms052lr, createdTime=Sun Dec 04 08:58:36 CST 2022, time=2022-12-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2152246, encodeId=eb00215224682, content=请问大佬们，7月18号发邮件送审了，状态显示为under consideration. 8月10号又出现了一个新的under consideration，也没发邮件，这是什么情况呢？是换审稿人了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc998444126, createdName=ms9000001100504946, createdTime=Fri Aug 11 12:15:43 CST 2023, time=2023-08-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2115901, encodeId=724a2115901ae, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：机制;肿瘤;非编码RNA<br>经验分享：折腾了4个月，总算原则性接收，也和大家分享一下过程： 第一轮 221029 Manuscript Received/Editor Assigned 221031 Manuscript UnderConsideration 221207 Manuscript Under Consideration 221218 Decision Made 221219 Decision Sent to Author/Waiting for Revision 第二轮 他修回是稿号后+R，不分大小都是Revise要重新提交 230113 Manuscript Received/Editor Assigned 230116 Manuscript UnderConsideration 230215 Manuscript Under Consideration 230218 Decision Made 230221 原则性接收 等上传再校稿，邮件写的是正式接收后缴费 二修基本1个月的时候非常焦虑，总的来说速度还算快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea4735673, createdName=ms052lr, createdTime=Wed Feb 22 11:36:34 CST 2023, time=2023-02-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0<br>经验分享：under consideration80天了，谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208246, encodeId=22051208246f3, content=这个杂志是什么时候要求交版面费啊？我proof都已经确认提交了，还没收到缴费的邮件。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/08/9c7077d12f45357f09cc4b2d21c25010.jpg, createdBy=f21b1476331, createdName=silencelang, createdTime=Sat Apr 02 22:06:41 CST 2022, time=2022-04-02, status=1, ipAttribution=)]
    2022-03-01 打工小熊🐻

    偏重的研究方向：机制
    经验分享：Cell death disease建议转投到cell death discovery，manuscripts under consideration后一个月再次manuscripts under consideration这种是什么情况？文件里见有外审文件

    18

    展开18条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1224377, encodeId=35f812243e740, content=偏重的研究方向：机制<br>经验分享：一审返修第二天就decision made，现在又过了三天了还没有发邮件，不清楚咋回事，好焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220120/e28ed7e5bf2d4eeb9c348df0072a7d10/99f48f1006314a1d9056038733877ef3.jpg, createdBy=a1235642632, createdName=打工小熊🐻, createdTime=Sat Jun 04 11:34:41 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184254, encodeId=7c4e1184254d3, content=请问大家缴费以后收到invoice了吗，怎么找杂志要invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ec24671199, createdName=303367978, createdTime=Fri Jan 14 16:06:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198273, encodeId=5e5d11982e3b7, content=偏重的研究方向：机制<br>经验分享：Cell death disease建议转投到cell death discovery，manuscripts under consideration后一个月再次manuscripts under consideration这种是什么情况？文件里见有外审文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220120/e28ed7e5bf2d4eeb9c348df0072a7d10/99f48f1006314a1d9056038733877ef3.jpg, createdBy=a1235642632, createdName=打工小熊🐻, createdTime=Tue Mar 01 09:28:13 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198524, encodeId=9062119852484, content=偏重的研究方向：机制;肿瘤<br>经验分享：最近审稿怎么这么慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd595570164, createdName=ms031, createdTime=Tue Mar 01 23:22:15 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003085, encodeId=01d31003085b3, content=各位大佬，你们支付过版面费后，会收到invoice嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Tue Jul 27 19:06:00 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104205, encodeId=b58e2104205a7, content=偏重的研究方向：肿瘤<br>经验分享：已经35天，还在Manuscript Under Consideration，写催稿信说已经送外审，还没有意见回来。。。。好煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea4735673, createdName=ms052lr, createdTime=Sun Dec 04 08:58:36 CST 2022, time=2022-12-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2152246, encodeId=eb00215224682, content=请问大佬们，7月18号发邮件送审了，状态显示为under consideration. 8月10号又出现了一个新的under consideration，也没发邮件，这是什么情况呢？是换审稿人了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc998444126, createdName=ms9000001100504946, createdTime=Fri Aug 11 12:15:43 CST 2023, time=2023-08-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2115901, encodeId=724a2115901ae, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：机制;肿瘤;非编码RNA<br>经验分享：折腾了4个月，总算原则性接收，也和大家分享一下过程： 第一轮 221029 Manuscript Received/Editor Assigned 221031 Manuscript UnderConsideration 221207 Manuscript Under Consideration 221218 Decision Made 221219 Decision Sent to Author/Waiting for Revision 第二轮 他修回是稿号后+R，不分大小都是Revise要重新提交 230113 Manuscript Received/Editor Assigned 230116 Manuscript UnderConsideration 230215 Manuscript Under Consideration 230218 Decision Made 230221 原则性接收 等上传再校稿，邮件写的是正式接收后缴费 二修基本1个月的时候非常焦虑，总的来说速度还算快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea4735673, createdName=ms052lr, createdTime=Wed Feb 22 11:36:34 CST 2023, time=2023-02-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0<br>经验分享：under consideration80天了，谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208246, encodeId=22051208246f3, content=这个杂志是什么时候要求交版面费啊？我proof都已经确认提交了，还没收到缴费的邮件。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/08/9c7077d12f45357f09cc4b2d21c25010.jpg, createdBy=f21b1476331, createdName=silencelang, createdTime=Sat Apr 02 22:06:41 CST 2022, time=2022-04-02, status=1, ipAttribution=)]
    2022-03-01 ms031

    偏重的研究方向：机制;肿瘤
    经验分享：最近审稿怎么这么慢呀

    16

    展开16条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1224377, encodeId=35f812243e740, content=偏重的研究方向：机制<br>经验分享：一审返修第二天就decision made，现在又过了三天了还没有发邮件，不清楚咋回事，好焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220120/e28ed7e5bf2d4eeb9c348df0072a7d10/99f48f1006314a1d9056038733877ef3.jpg, createdBy=a1235642632, createdName=打工小熊🐻, createdTime=Sat Jun 04 11:34:41 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184254, encodeId=7c4e1184254d3, content=请问大家缴费以后收到invoice了吗，怎么找杂志要invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ec24671199, createdName=303367978, createdTime=Fri Jan 14 16:06:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198273, encodeId=5e5d11982e3b7, content=偏重的研究方向：机制<br>经验分享：Cell death disease建议转投到cell death discovery，manuscripts under consideration后一个月再次manuscripts under consideration这种是什么情况？文件里见有外审文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220120/e28ed7e5bf2d4eeb9c348df0072a7d10/99f48f1006314a1d9056038733877ef3.jpg, createdBy=a1235642632, createdName=打工小熊🐻, createdTime=Tue Mar 01 09:28:13 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198524, encodeId=9062119852484, content=偏重的研究方向：机制;肿瘤<br>经验分享：最近审稿怎么这么慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd595570164, createdName=ms031, createdTime=Tue Mar 01 23:22:15 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003085, encodeId=01d31003085b3, content=各位大佬，你们支付过版面费后，会收到invoice嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Tue Jul 27 19:06:00 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104205, encodeId=b58e2104205a7, content=偏重的研究方向：肿瘤<br>经验分享：已经35天，还在Manuscript Under Consideration，写催稿信说已经送外审，还没有意见回来。。。。好煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea4735673, createdName=ms052lr, createdTime=Sun Dec 04 08:58:36 CST 2022, time=2022-12-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2152246, encodeId=eb00215224682, content=请问大佬们，7月18号发邮件送审了，状态显示为under consideration. 8月10号又出现了一个新的under consideration，也没发邮件，这是什么情况呢？是换审稿人了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc998444126, createdName=ms9000001100504946, createdTime=Fri Aug 11 12:15:43 CST 2023, time=2023-08-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2115901, encodeId=724a2115901ae, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：机制;肿瘤;非编码RNA<br>经验分享：折腾了4个月，总算原则性接收，也和大家分享一下过程： 第一轮 221029 Manuscript Received/Editor Assigned 221031 Manuscript UnderConsideration 221207 Manuscript Under Consideration 221218 Decision Made 221219 Decision Sent to Author/Waiting for Revision 第二轮 他修回是稿号后+R，不分大小都是Revise要重新提交 230113 Manuscript Received/Editor Assigned 230116 Manuscript UnderConsideration 230215 Manuscript Under Consideration 230218 Decision Made 230221 原则性接收 等上传再校稿，邮件写的是正式接收后缴费 二修基本1个月的时候非常焦虑，总的来说速度还算快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea4735673, createdName=ms052lr, createdTime=Wed Feb 22 11:36:34 CST 2023, time=2023-02-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0<br>经验分享：under consideration80天了，谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208246, encodeId=22051208246f3, content=这个杂志是什么时候要求交版面费啊？我proof都已经确认提交了，还没收到缴费的邮件。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/08/9c7077d12f45357f09cc4b2d21c25010.jpg, createdBy=f21b1476331, createdName=silencelang, createdTime=Sat Apr 02 22:06:41 CST 2022, time=2022-04-02, status=1, ipAttribution=)]
    2021-07-27 能帮我发SCI嘛

    各位大佬，你们支付过版面费后，会收到invoice嘛？

    16

    展开16条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1224377, encodeId=35f812243e740, content=偏重的研究方向：机制<br>经验分享：一审返修第二天就decision made，现在又过了三天了还没有发邮件，不清楚咋回事，好焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220120/e28ed7e5bf2d4eeb9c348df0072a7d10/99f48f1006314a1d9056038733877ef3.jpg, createdBy=a1235642632, createdName=打工小熊🐻, createdTime=Sat Jun 04 11:34:41 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184254, encodeId=7c4e1184254d3, content=请问大家缴费以后收到invoice了吗，怎么找杂志要invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ec24671199, createdName=303367978, createdTime=Fri Jan 14 16:06:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198273, encodeId=5e5d11982e3b7, content=偏重的研究方向：机制<br>经验分享：Cell death disease建议转投到cell death discovery，manuscripts under consideration后一个月再次manuscripts under consideration这种是什么情况？文件里见有外审文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220120/e28ed7e5bf2d4eeb9c348df0072a7d10/99f48f1006314a1d9056038733877ef3.jpg, createdBy=a1235642632, createdName=打工小熊🐻, createdTime=Tue Mar 01 09:28:13 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198524, encodeId=9062119852484, content=偏重的研究方向：机制;肿瘤<br>经验分享：最近审稿怎么这么慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd595570164, createdName=ms031, createdTime=Tue Mar 01 23:22:15 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003085, encodeId=01d31003085b3, content=各位大佬，你们支付过版面费后，会收到invoice嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Tue Jul 27 19:06:00 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104205, encodeId=b58e2104205a7, content=偏重的研究方向：肿瘤<br>经验分享：已经35天，还在Manuscript Under Consideration，写催稿信说已经送外审，还没有意见回来。。。。好煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea4735673, createdName=ms052lr, createdTime=Sun Dec 04 08:58:36 CST 2022, time=2022-12-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2152246, encodeId=eb00215224682, content=请问大佬们，7月18号发邮件送审了，状态显示为under consideration. 8月10号又出现了一个新的under consideration，也没发邮件，这是什么情况呢？是换审稿人了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc998444126, createdName=ms9000001100504946, createdTime=Fri Aug 11 12:15:43 CST 2023, time=2023-08-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2115901, encodeId=724a2115901ae, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：机制;肿瘤;非编码RNA<br>经验分享：折腾了4个月，总算原则性接收，也和大家分享一下过程： 第一轮 221029 Manuscript Received/Editor Assigned 221031 Manuscript UnderConsideration 221207 Manuscript Under Consideration 221218 Decision Made 221219 Decision Sent to Author/Waiting for Revision 第二轮 他修回是稿号后+R，不分大小都是Revise要重新提交 230113 Manuscript Received/Editor Assigned 230116 Manuscript UnderConsideration 230215 Manuscript Under Consideration 230218 Decision Made 230221 原则性接收 等上传再校稿，邮件写的是正式接收后缴费 二修基本1个月的时候非常焦虑，总的来说速度还算快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea4735673, createdName=ms052lr, createdTime=Wed Feb 22 11:36:34 CST 2023, time=2023-02-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0<br>经验分享：under consideration80天了，谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208246, encodeId=22051208246f3, content=这个杂志是什么时候要求交版面费啊？我proof都已经确认提交了，还没收到缴费的邮件。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/08/9c7077d12f45357f09cc4b2d21c25010.jpg, createdBy=f21b1476331, createdName=silencelang, createdTime=Sat Apr 02 22:06:41 CST 2022, time=2022-04-02, status=1, ipAttribution=)]
    2022-12-04 ms052lr 来自江苏省

    偏重的研究方向：肿瘤
    经验分享：已经35天，还在Manuscript Under Consideration，写催稿信说已经送外审，还没有意见回来。。。。好煎熬

    15

    展开15条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1224377, encodeId=35f812243e740, content=偏重的研究方向：机制<br>经验分享：一审返修第二天就decision made，现在又过了三天了还没有发邮件，不清楚咋回事，好焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220120/e28ed7e5bf2d4eeb9c348df0072a7d10/99f48f1006314a1d9056038733877ef3.jpg, createdBy=a1235642632, createdName=打工小熊🐻, createdTime=Sat Jun 04 11:34:41 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184254, encodeId=7c4e1184254d3, content=请问大家缴费以后收到invoice了吗，怎么找杂志要invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ec24671199, createdName=303367978, createdTime=Fri Jan 14 16:06:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198273, encodeId=5e5d11982e3b7, content=偏重的研究方向：机制<br>经验分享：Cell death disease建议转投到cell death discovery，manuscripts under consideration后一个月再次manuscripts under consideration这种是什么情况？文件里见有外审文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220120/e28ed7e5bf2d4eeb9c348df0072a7d10/99f48f1006314a1d9056038733877ef3.jpg, createdBy=a1235642632, createdName=打工小熊🐻, createdTime=Tue Mar 01 09:28:13 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198524, encodeId=9062119852484, content=偏重的研究方向：机制;肿瘤<br>经验分享：最近审稿怎么这么慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd595570164, createdName=ms031, createdTime=Tue Mar 01 23:22:15 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003085, encodeId=01d31003085b3, content=各位大佬，你们支付过版面费后，会收到invoice嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Tue Jul 27 19:06:00 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104205, encodeId=b58e2104205a7, content=偏重的研究方向：肿瘤<br>经验分享：已经35天，还在Manuscript Under Consideration，写催稿信说已经送外审，还没有意见回来。。。。好煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea4735673, createdName=ms052lr, createdTime=Sun Dec 04 08:58:36 CST 2022, time=2022-12-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2152246, encodeId=eb00215224682, content=请问大佬们，7月18号发邮件送审了，状态显示为under consideration. 8月10号又出现了一个新的under consideration，也没发邮件，这是什么情况呢？是换审稿人了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc998444126, createdName=ms9000001100504946, createdTime=Fri Aug 11 12:15:43 CST 2023, time=2023-08-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2115901, encodeId=724a2115901ae, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：机制;肿瘤;非编码RNA<br>经验分享：折腾了4个月，总算原则性接收，也和大家分享一下过程： 第一轮 221029 Manuscript Received/Editor Assigned 221031 Manuscript UnderConsideration 221207 Manuscript Under Consideration 221218 Decision Made 221219 Decision Sent to Author/Waiting for Revision 第二轮 他修回是稿号后+R，不分大小都是Revise要重新提交 230113 Manuscript Received/Editor Assigned 230116 Manuscript UnderConsideration 230215 Manuscript Under Consideration 230218 Decision Made 230221 原则性接收 等上传再校稿，邮件写的是正式接收后缴费 二修基本1个月的时候非常焦虑，总的来说速度还算快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea4735673, createdName=ms052lr, createdTime=Wed Feb 22 11:36:34 CST 2023, time=2023-02-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0<br>经验分享：under consideration80天了，谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208246, encodeId=22051208246f3, content=这个杂志是什么时候要求交版面费啊？我proof都已经确认提交了，还没收到缴费的邮件。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/08/9c7077d12f45357f09cc4b2d21c25010.jpg, createdBy=f21b1476331, createdName=silencelang, createdTime=Sat Apr 02 22:06:41 CST 2022, time=2022-04-02, status=1, ipAttribution=)]
    2023-08-11 ms9000001100504946 来自重庆

    请问大佬们，7月18号发邮件送审了，状态显示为under consideration. 8月10号又出现了一个新的under consideration，也没发邮件，这是什么情况呢？是换审稿人了吗？

    14

    展开14条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1224377, encodeId=35f812243e740, content=偏重的研究方向：机制<br>经验分享：一审返修第二天就decision made，现在又过了三天了还没有发邮件，不清楚咋回事，好焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220120/e28ed7e5bf2d4eeb9c348df0072a7d10/99f48f1006314a1d9056038733877ef3.jpg, createdBy=a1235642632, createdName=打工小熊🐻, createdTime=Sat Jun 04 11:34:41 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184254, encodeId=7c4e1184254d3, content=请问大家缴费以后收到invoice了吗，怎么找杂志要invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ec24671199, createdName=303367978, createdTime=Fri Jan 14 16:06:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198273, encodeId=5e5d11982e3b7, content=偏重的研究方向：机制<br>经验分享：Cell death disease建议转投到cell death discovery，manuscripts under consideration后一个月再次manuscripts under consideration这种是什么情况？文件里见有外审文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220120/e28ed7e5bf2d4eeb9c348df0072a7d10/99f48f1006314a1d9056038733877ef3.jpg, createdBy=a1235642632, createdName=打工小熊🐻, createdTime=Tue Mar 01 09:28:13 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198524, encodeId=9062119852484, content=偏重的研究方向：机制;肿瘤<br>经验分享：最近审稿怎么这么慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd595570164, createdName=ms031, createdTime=Tue Mar 01 23:22:15 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003085, encodeId=01d31003085b3, content=各位大佬，你们支付过版面费后，会收到invoice嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Tue Jul 27 19:06:00 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104205, encodeId=b58e2104205a7, content=偏重的研究方向：肿瘤<br>经验分享：已经35天，还在Manuscript Under Consideration，写催稿信说已经送外审，还没有意见回来。。。。好煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea4735673, createdName=ms052lr, createdTime=Sun Dec 04 08:58:36 CST 2022, time=2022-12-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2152246, encodeId=eb00215224682, content=请问大佬们，7月18号发邮件送审了，状态显示为under consideration. 8月10号又出现了一个新的under consideration，也没发邮件，这是什么情况呢？是换审稿人了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc998444126, createdName=ms9000001100504946, createdTime=Fri Aug 11 12:15:43 CST 2023, time=2023-08-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2115901, encodeId=724a2115901ae, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：机制;肿瘤;非编码RNA<br>经验分享：折腾了4个月，总算原则性接收，也和大家分享一下过程： 第一轮 221029 Manuscript Received/Editor Assigned 221031 Manuscript UnderConsideration 221207 Manuscript Under Consideration 221218 Decision Made 221219 Decision Sent to Author/Waiting for Revision 第二轮 他修回是稿号后+R，不分大小都是Revise要重新提交 230113 Manuscript Received/Editor Assigned 230116 Manuscript UnderConsideration 230215 Manuscript Under Consideration 230218 Decision Made 230221 原则性接收 等上传再校稿，邮件写的是正式接收后缴费 二修基本1个月的时候非常焦虑，总的来说速度还算快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea4735673, createdName=ms052lr, createdTime=Wed Feb 22 11:36:34 CST 2023, time=2023-02-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0<br>经验分享：under consideration80天了，谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208246, encodeId=22051208246f3, content=这个杂志是什么时候要求交版面费啊？我proof都已经确认提交了，还没收到缴费的邮件。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/08/9c7077d12f45357f09cc4b2d21c25010.jpg, createdBy=f21b1476331, createdName=silencelang, createdTime=Sat Apr 02 22:06:41 CST 2022, time=2022-04-02, status=1, ipAttribution=)]
    2023-02-22 ms052lr 来自江苏省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：机制;肿瘤;非编码RNA
    经验分享：折腾了4个月，总算原则性接收，也和大家分享一下过程： 第一轮 221029 Manuscript Received/Editor Assigned 221031 Manuscript UnderConsideration 221207 Manuscript Under Consideration 221218 Decision Made 221219 Decision Sent to Author/Waiting for Revision 第二轮 他修回是稿号后+R，不分大小都是Revise要重新提交 230113 Manuscript Received/Editor Assigned 230116 Manuscript UnderConsideration 230215 Manuscript Under Consideration 230218 Decision Made 230221 原则性接收 等上传再校稿，邮件写的是正式接收后缴费 二修基本1个月的时候非常焦虑，总的来说速度还算快的

    14

    展开14条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1224377, encodeId=35f812243e740, content=偏重的研究方向：机制<br>经验分享：一审返修第二天就decision made，现在又过了三天了还没有发邮件，不清楚咋回事，好焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220120/e28ed7e5bf2d4eeb9c348df0072a7d10/99f48f1006314a1d9056038733877ef3.jpg, createdBy=a1235642632, createdName=打工小熊🐻, createdTime=Sat Jun 04 11:34:41 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184254, encodeId=7c4e1184254d3, content=请问大家缴费以后收到invoice了吗，怎么找杂志要invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ec24671199, createdName=303367978, createdTime=Fri Jan 14 16:06:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198273, encodeId=5e5d11982e3b7, content=偏重的研究方向：机制<br>经验分享：Cell death disease建议转投到cell death discovery，manuscripts under consideration后一个月再次manuscripts under consideration这种是什么情况？文件里见有外审文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220120/e28ed7e5bf2d4eeb9c348df0072a7d10/99f48f1006314a1d9056038733877ef3.jpg, createdBy=a1235642632, createdName=打工小熊🐻, createdTime=Tue Mar 01 09:28:13 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198524, encodeId=9062119852484, content=偏重的研究方向：机制;肿瘤<br>经验分享：最近审稿怎么这么慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd595570164, createdName=ms031, createdTime=Tue Mar 01 23:22:15 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003085, encodeId=01d31003085b3, content=各位大佬，你们支付过版面费后，会收到invoice嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Tue Jul 27 19:06:00 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104205, encodeId=b58e2104205a7, content=偏重的研究方向：肿瘤<br>经验分享：已经35天，还在Manuscript Under Consideration，写催稿信说已经送外审，还没有意见回来。。。。好煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea4735673, createdName=ms052lr, createdTime=Sun Dec 04 08:58:36 CST 2022, time=2022-12-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2152246, encodeId=eb00215224682, content=请问大佬们，7月18号发邮件送审了，状态显示为under consideration. 8月10号又出现了一个新的under consideration，也没发邮件，这是什么情况呢？是换审稿人了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc998444126, createdName=ms9000001100504946, createdTime=Fri Aug 11 12:15:43 CST 2023, time=2023-08-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2115901, encodeId=724a2115901ae, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：机制;肿瘤;非编码RNA<br>经验分享：折腾了4个月，总算原则性接收，也和大家分享一下过程： 第一轮 221029 Manuscript Received/Editor Assigned 221031 Manuscript UnderConsideration 221207 Manuscript Under Consideration 221218 Decision Made 221219 Decision Sent to Author/Waiting for Revision 第二轮 他修回是稿号后+R，不分大小都是Revise要重新提交 230113 Manuscript Received/Editor Assigned 230116 Manuscript UnderConsideration 230215 Manuscript Under Consideration 230218 Decision Made 230221 原则性接收 等上传再校稿，邮件写的是正式接收后缴费 二修基本1个月的时候非常焦虑，总的来说速度还算快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea4735673, createdName=ms052lr, createdTime=Wed Feb 22 11:36:34 CST 2023, time=2023-02-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0<br>经验分享：under consideration80天了，谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208246, encodeId=22051208246f3, content=这个杂志是什么时候要求交版面费啊？我proof都已经确认提交了，还没收到缴费的邮件。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/08/9c7077d12f45357f09cc4b2d21c25010.jpg, createdBy=f21b1476331, createdName=silencelang, createdTime=Sat Apr 02 22:06:41 CST 2022, time=2022-04-02, status=1, ipAttribution=)]
    2022-08-19 121c6f2dm84(暂无昵称)

    审稿速度:6.0
    经验分享：under consideration80天了，谁说这个快来着。。

    13

    展开13条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1224377, encodeId=35f812243e740, content=偏重的研究方向：机制<br>经验分享：一审返修第二天就decision made，现在又过了三天了还没有发邮件，不清楚咋回事，好焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220120/e28ed7e5bf2d4eeb9c348df0072a7d10/99f48f1006314a1d9056038733877ef3.jpg, createdBy=a1235642632, createdName=打工小熊🐻, createdTime=Sat Jun 04 11:34:41 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184254, encodeId=7c4e1184254d3, content=请问大家缴费以后收到invoice了吗，怎么找杂志要invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ec24671199, createdName=303367978, createdTime=Fri Jan 14 16:06:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198273, encodeId=5e5d11982e3b7, content=偏重的研究方向：机制<br>经验分享：Cell death disease建议转投到cell death discovery，manuscripts under consideration后一个月再次manuscripts under consideration这种是什么情况？文件里见有外审文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220120/e28ed7e5bf2d4eeb9c348df0072a7d10/99f48f1006314a1d9056038733877ef3.jpg, createdBy=a1235642632, createdName=打工小熊🐻, createdTime=Tue Mar 01 09:28:13 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198524, encodeId=9062119852484, content=偏重的研究方向：机制;肿瘤<br>经验分享：最近审稿怎么这么慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd595570164, createdName=ms031, createdTime=Tue Mar 01 23:22:15 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003085, encodeId=01d31003085b3, content=各位大佬，你们支付过版面费后，会收到invoice嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Tue Jul 27 19:06:00 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104205, encodeId=b58e2104205a7, content=偏重的研究方向：肿瘤<br>经验分享：已经35天，还在Manuscript Under Consideration，写催稿信说已经送外审，还没有意见回来。。。。好煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea4735673, createdName=ms052lr, createdTime=Sun Dec 04 08:58:36 CST 2022, time=2022-12-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2152246, encodeId=eb00215224682, content=请问大佬们，7月18号发邮件送审了，状态显示为under consideration. 8月10号又出现了一个新的under consideration，也没发邮件，这是什么情况呢？是换审稿人了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc998444126, createdName=ms9000001100504946, createdTime=Fri Aug 11 12:15:43 CST 2023, time=2023-08-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2115901, encodeId=724a2115901ae, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：机制;肿瘤;非编码RNA<br>经验分享：折腾了4个月，总算原则性接收，也和大家分享一下过程： 第一轮 221029 Manuscript Received/Editor Assigned 221031 Manuscript UnderConsideration 221207 Manuscript Under Consideration 221218 Decision Made 221219 Decision Sent to Author/Waiting for Revision 第二轮 他修回是稿号后+R，不分大小都是Revise要重新提交 230113 Manuscript Received/Editor Assigned 230116 Manuscript UnderConsideration 230215 Manuscript Under Consideration 230218 Decision Made 230221 原则性接收 等上传再校稿，邮件写的是正式接收后缴费 二修基本1个月的时候非常焦虑，总的来说速度还算快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea4735673, createdName=ms052lr, createdTime=Wed Feb 22 11:36:34 CST 2023, time=2023-02-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0<br>经验分享：under consideration80天了，谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208246, encodeId=22051208246f3, content=这个杂志是什么时候要求交版面费啊？我proof都已经确认提交了，还没收到缴费的邮件。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/08/9c7077d12f45357f09cc4b2d21c25010.jpg, createdBy=f21b1476331, createdName=silencelang, createdTime=Sat Apr 02 22:06:41 CST 2022, time=2022-04-02, status=1, ipAttribution=)]
    2022-04-02 silencelang

    这个杂志是什么时候要求交版面费啊？我proof都已经确认提交了，还没收到缴费的邮件。

    13

    展开13条回复
共500条页码: 2/50页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分